REWARDS- In-stent Restenosis
NCT03008772 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2020-10-19
Summary
To define the long-term incidence and frequency of ISR follow DES implantation. Compare the clinical presentation, treatment and intervention success among de novo coronary artery stenosis and DES ISR.
Compare short- and long-term outcomes of de novo coronary artery stenosis and DES ISR, assessed by incidence of mortality, MACE, MI, and TLR/TVR at index hospitalization, 30 days, 6 months, 1 year, 3 years, and 5 years, if available.
Conditions
- In-Stent Coronary Artery Restenosis
Sponsors & Collaborators
-
Medstar Health Research Institute
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-02-28
- Primary Completion
- 2023-01-31
- Completion
- 2024-01-31
Countries
- United States
Study Locations
More Related Trials
-
A Prospective, Multi-center, Single Arm Study Evaluating the Express™ Renal Premounted Stent System in the Treatment of Atherosclerotic Lesions in the Aortorenal Ostium.
NCT00597142 ·Status: COMPLETED ·Phase: PHASE4
-
Over and Under/Aneugraft Pericardium Covered Stent Long Term Follow up Registry
NCT01307553 ·Status: UNKNOWN
-
Bare Metal Bifurcation Stent Clinical Trial in Humans
NCT00607321 ·Status: COMPLETED ·Phase: NA
-
DCS Versus DES for One-month DAPT in Patients With ACS: ONE-PASS Trial
NCT05305482 ·Status: RECRUITING ·Phase: NA
-
A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
NCT02100722 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study of Photopheresis Post Angioplasty
NCT00157001 ·Status: TERMINATED ·Phase: PHASE2
-
A Multicenter Trial of Localized Radiation Therapy to Inhibit Restenosis (GAMMA V)
NCT00232778 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
RESOLUTE International Registry: Evaluation of the Resolute Zotarolimus-Eluting Stent System in a 'Real-World' Patient Population
NCT00752128 ·Status: COMPLETED
-
IRIS-Firehawk® Cohort in the IRIS-DES Registry
NCT03380286 ·Status: WITHDRAWN
-
Investigation of Stent-grafts in Aortic Dissection (INSTEAD)
NCT01415804 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Post-Approval Trial of the Talent™ Abdominal Stent Graft to Treat Aortic Aneurysms
NCT00816062 ·Status: COMPLETED ·Phase: NA
-
RESILIENCE Trial: Evaluation of the Durability of Aortic Bioprostheses/Valves With RESILIA Tissue in Subjects Under 65
NCT03680040 ·Status: TERMINATED
-
The Study to Compare the Cordis SMART™ Stent System With the Bard® Luminexx™ Stent
NCT00235131 ·Status: COMPLETED ·Phase: PHASE4
-
Standardized Procedure for Intracranial Drug-Eluting Stenting in the Treatment of Intracranial Atherosclerotic Stenosis
NCT06857058 ·Status: RECRUITING ·Phase: NA
-
REPRISE II: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System
NCT01627691 ·Status: COMPLETED ·Phase: NA
-
ReZolve2 Clinical Investigation
NCT01845311 ·Status: COMPLETED ·Phase: NA
-
A Prospective Study of the Performance of the Bard® LifeStent® Vascular Stent Systems (REALITY)
NCT01920308 ·Status: COMPLETED
-
Genomics of In-Stent Restenosis
NCT00341562 ·Status: COMPLETED
-
Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment With Scoring Balloon Pre-dilatation (RIBS VI Scoring)
NCT03069066 ·Status: UNKNOWN ·Phase: PHASE4
-
Post-Approval Study for the MOSAIC® Bioprostheses
NCT01574625 ·Status: COMPLETED
-
A Real-World Study on Distal Aortic Remodeling for Stanford Type B Aortic Dissection With Fabulous Thoracic Aortic Stent System
NCT05883592 ·Status: UNKNOWN
-
ARISE: Evaluation of the GORE® Ascending Stent Graft in the Treatment of DeBakey Type I/II Aortic Dissection
NCT02380716 ·Status: COMPLETED
-
Controlled Arterial Protection to Ultimately Remove Embolic Material
NCT06103591 ·Status: COMPLETED ·Phase: NA
-
PERVIDEO I Registry, The Lutonix Paclitaxel-Coated Balloon Catheter for the Treatment of Coronary In-Stent Restenosis
NCT00916279 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis
NCT00287573 ·Status: COMPLETED ·Phase: PHASE2/PHASE3